A board-certified internist and a Fulbright scholar, Dr. Knecht has developed insights into the health care industry through experiences in pharmaceutical entrepreneurship, life science strategy consulting, patient care and population health research.
Dr. Knecht currently serves as head of Clinical Strategy for Aetna. His responsibilities include creation and execution of Aetna’s clinical strategy which enhances the value of health care afforded to members. This role includes supporting external partnering efforts as well as identifying and implementing strategic initiatives, in care management, and data analytics. Dr. Knecht also serves as interim Head of the National Clinical Appeals Unit, a nursing team that processes Aetna’s clinical commercial appeals. He also serves as Chief of Staff to Dr. Hal Paz, Aetna’s Chief Medical Officer.
After graduating with honors from Dartmouth College, Dr. Knecht received a joint MD/MBA from Weill Cornell Medical College and Johnson Graduate School of Management where he was a recipient of the Lee Family Scholarship. During his residency in internal medicine at Mount Sinai Hospital in New York, he received the competitive “Advancing Clinical Excellence in Medicine” grant from the Department of Internal Medicine. Dr. Knecht is also the recipient of the “Silver Apple Teaching Award,” recognizing his commitment to medical education.
Prior to joining Aetna, Dr. Knecht worked at Frankel Group, which was acquired by Huron Life Sciences; there he provided strategic counsel to leading life science companies on a range of business challenges. He performed market analyses, competitive intelligence projects and due diligence assessments on biotechnology and pharmaceutical assets in varying stages of development.
As a Fulbright Scholar in medical sciences, Dr. Knecht performed research that explored health care deficiencies of the Bedouin community inhabiting the Negev region in Israel.